Search results
Results from the WOW.Com Content Network
IBA has developed an affinity chromatography system for non-magnetic isolation of peripheral blood mononuclear cells, T cells, B cells and other cells of interest. This technology is known as Fab-TACS (Traceless Affinity Cell Selection) and is based on Strep-tagged Fab fragments, which reversibly capture and release the target cells.
IBA GROUP is an international IT company founded in 1993. [ 1 ] [ 2 ] The company’s focus areas include enterprise applications, mainframe systems, SAP solutions, cloud technologies, and RPA/ML/AI solutions.
Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific .
(Reuters) -The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' drug to treat a rare genetic disorder, making it the company's first wholly-owned drug, the health regulator's ...
Aptalis was a company in the pharmaceutical industry.In January 2014, the company was acquired by Forest Laboratories (acquired by Allergan) for $675 million.Through a series of acquisitions, the company is now a contract development and manufacturing organization and rebranded as Adare Phama Solutions, headquartered in Lawrenceville, New Jersey.
Collins says that "an eye massager mask offers a non-pharmaceutical way to relax muscles, reduce tension and encourage rest, helping relieve symptoms tied to these hormonal shifts."
The investors planned to take Macy’s private and consider spinning off its real estate assets or separating its online operations from brick-and-mortar stores.
1999: Predecessor Endo Pharmaceuticals Holdings agreed to buy Algos Pharmaceutical Corporation, in a bid to gain additional products for the painkiller market. [14] [6] 2006: Endo acquired RxKinetix, leading to a fall in profits. [15] [16] 2009: Endo bought Indevus Pharmaceuticals to diversify into endocrinology and oncology. [17]